Daniel S. Graciaa

Infectious Disease

550 Peachtree Street Northeast
MedicalOfficeTower
Atlanta, GA 30308

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Infectious diseases

Published: February 26, 2026

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Journal: Vaccine

Published: October 31, 2025

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 10, 2025

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.

Journal: Vaccine

Published: February 17, 2025

Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults.

Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults.

Journal: Vaccine

Published: August 14, 2024

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Journal: Nature communications

Published: July 19, 2024

Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines.

Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines.

Journal: The Journal of infectious diseases

Published: July 18, 2024

Human Immunodeficiency Virus Vaccine: Promise and Challenges.

Human Immunodeficiency Virus Vaccine: Promise and Challenges.

Journal: Infectious disease clinics of North America

Published: June 14, 2024

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.

Journal: JAMA network open

Published: July 13, 2023

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.

Journal: Research square

Published: May 19, 2023

Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies.

Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies.

Journal: Expert review of anti-infective therapy

Published: May 02, 2023

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Journal: Nature medicine

Published: March 03, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026